跳至主要内容
临床试验/NCT00638846
NCT00638846已完成不适用

Multi-Center Evaluation Of Two Silicone Hydrogel Toric Contact Lenses

Johnson & Johnson Vision Care, Inc.19 个研究点 分布在 1 个国家目标入组 276 人开始时间: 2008年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
276
试验地点
19
主要终点
Lens Orientation

研究概览

简要总结

Evaluation of the clinical performance of two toric contact lenses in a 2-week, single masked (subject), daily wear, randomized, bilateral, parallel group study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Be between 18 and 45 years of age.
  • •Sign Written Informed Consent (See separate document).
  • •Be an existing successful daily wear toric soft contact lens.
  • •Require a visual correction in both eyes (monovision or uniocular fitting is NOT allowed).
  • •Does not require presbyopic correction (can read J1 @ normal reading distance).
  • •Have a sphere requirement in the range -1.00 and -5.00D (-5.25D refractive)
  • •Have refractive astigmatism between 0.75D and 2.50D in both eyes.
  • •Achieve visual acuity of 20/30 or better in each eye with spherical distance correction.
  • •Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having:
  • •No amblyopia.
  • •No evidence of lid abnormality or infection.
  • •No conjunctival abnormality or infection.
  • •No clinically significant slit lamp findings (i.e. stromal edema, vascularisation, infiltrates or abnormal opacities).
  • •No other active ocular disease.

排除标准

  • •Requires concurrent ocular medication.
  • •Clinically significant (Grade 3 or 4) corneal stromal haze, corneal vascularisation, tarsal abnormalities, bulbar hyperemia, limbal hyperemia, or any other abnormality of the cornea that would contraindicate contact lens wear.
  • •Corneal staining Grade 3 in more than one region.
  • •Has had refractive surgery. Has had eye injury/surgery within 8 weeks immediately prior to enrolment for this study.
  • •Abnormal lacrimal secretions.
  • •Pre-existing ocular irritation that would preclude contact lens fitting.
  • •Keratoconus or other corneal irregularity.
  • •Polymethyl methacrylate (PMMA) or Rigid Gas Permeable (RGP) lens wear in the previous 8 weeks
  • •Extended lens wear in last 3 months.
  • •Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
  • •Diabetic.
  • •Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
  • •Pregnancy, lactating or planning a pregnancy at the time of enrolment.
  • •Participation in any concurrent clinical trial or in last 60 days.

研究组 & 干预措施

senofilcon A toric

Experimental

senofilcon A, daily wear, toric contact lens worn for two weeks

干预措施: senofilcon A toric (Device)

balafilcon A toric

Active Comparator

balafilcon A, daily wear, toric contact lens worn for two weeks

干预措施: balafilcon A toric (Device)

结局指标

主要结局

Lens Orientation

时间窗: 1 minute after insertion

Proportion of eyes with lens orientation within 5 degrees of optimal

Lens Stability

时间窗: 10-15 minutes after insertion

Lens stability is measured as the amount of rotation induced from blink after the lens has settled.

Subjective Comfort

时间窗: 2 weeks of lens wear

Subjective comfort was derived from a weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response. \>0 = comfortable, \< 0 = uncomfortable. Combined measures from Week 1 and Week 5.

次要结局

  • Time to Fit Lens(after lens insertion)
  • Subjective Lens Vision(measured at 1 and 2 weeks)
  • Overall Corneal Staining(After 2 weeks use)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (19)

Loading locations...

相似试验